# Efficacy Study of Pre-emptive Etoricoxib for Postoperative Pain and Functional Outcome in Total Knee Arthroplasty

> **NCT01246362** · PHASE2 · COMPLETED · sponsor: **Singapore General Hospital** · enrollment: 65 (actual)

## Conditions studied

- Knee Osteoarthritis

## Interventions

- **DRUG:** Control
- **DRUG:** Etoricoxib

## Key facts

- **NCT ID:** NCT01246362
- **Lead sponsor:** Singapore General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-07
- **Primary completion:** 2014-01
- **Final completion:** 2014-01
- **Target enrollment:** 65 (ACTUAL)
- **Last updated:** 2017-02-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01246362

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01246362, "Efficacy Study of Pre-emptive Etoricoxib for Postoperative Pain and Functional Outcome in Total Knee Arthroplasty". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01246362. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*